Disclaimer: The views expressed are those of the authors and do not necessarily represent the official position of the U.S. Food and Drug Administration.
Research Article
You have full text access to this OnlineOpen article
Use of parenteral iron products and serious anaphylactic-type reactions†‡§
Article first published online: 15 JUN 2010
DOI: 10.1002/ajh.21794
Published 2010 Wiley-Liss, Inc.
Additional Information
How to Cite
Wysowski, D. K., Swartz, L., Vicky Borders-Hemphill, B., Goulding, M. R. and Dormitzer, C. (2010), Use of parenteral iron products and serious anaphylactic-type reactions. Am. J. Hematol., 85: 650–654. doi: 10.1002/ajh.21794
- †
- ‡
Conflict of interest: Nothing to report.
- §
This article is a US Government work and, as such, is in the public domain in the United States of America.
Publication History
- Issue published online: 25 AUG 2010
- Article first published online: 15 JUN 2010
- Manuscript Accepted: 9 JUN 2010
- Manuscript Revised: 8 JUN 2010
- Manuscript Received: 14 JAN 2010
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, Iron therapy in patients with chronic kidney disease, Transfusion Alternatives in Transfusion Medicine, 2012, 12, 2Direct Link:
- 2
- 3, , Ferumoxytol for the treatment of iron deficiency, Expert Review of Hematology, 2011, 4, 4, 399
- 4, , , , , , , , , IV iron sucrose for cancer and/or chemotherapy-induced anemia in patients treated with erythropoiesis-stimulating agents, Community Oncology, 2011, 8, 6, 270
- 5

1096-8652/asset/olbannerleft.gif?v=1&s=d9288d4b31f0b8e9a1eb2d195cb165e0aa1d7a97)
1096-8652/asset/olbannerright.gif?v=1&s=78488ac502104a3d829e729353def6ce62dc1e29)
